Salla M. Kangas

463 total citations
21 papers, 316 citations indexed

About

Salla M. Kangas is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Salla M. Kangas has authored 21 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Salla M. Kangas's work include Genomics and Rare Diseases (5 papers), Mitochondrial Function and Pathology (4 papers) and RNA regulation and disease (4 papers). Salla M. Kangas is often cited by papers focused on Genomics and Rare Diseases (5 papers), Mitochondrial Function and Pathology (4 papers) and RNA regulation and disease (4 papers). Salla M. Kangas collaborates with scholars based in Finland, Japan and United States. Salla M. Kangas's co-authors include Anthony M. Heape, Sirkku Peltonen, Juha Peltonen, Marja Nissinen, Miika Arvonen, Mysore V. Tejesvi, Tuomo J. Karttunen, Anna Maria Pirttilä, Paula Vähäsalo and Matti Myllykoski and has published in prestigious journals such as Journal of Neurochemistry, European Journal of Neuroscience and Movement Disorders.

In The Last Decade

Salla M. Kangas

18 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salla M. Kangas Finland 8 168 120 49 42 34 21 316
Hiroko Shigemi Japan 11 104 0.6× 69 0.6× 46 0.9× 25 0.6× 27 0.8× 29 355
Louisa S. Tang United States 10 184 1.1× 68 0.6× 65 1.3× 39 0.9× 73 2.1× 12 454
Janaina Alves Puerto Rico 9 192 1.1× 64 0.5× 28 0.6× 52 1.2× 13 0.4× 14 351
Makoto Samukawa Japan 13 69 0.4× 141 1.2× 20 0.4× 5 0.1× 21 0.6× 36 366
Dominique Bollino United States 10 123 0.7× 42 0.3× 57 1.2× 10 0.2× 44 1.3× 19 388
Ali Mohammed Iraq 11 60 0.4× 65 0.5× 14 0.3× 24 0.6× 14 0.4× 39 335
Fernando Pradella Brazil 11 95 0.6× 36 0.3× 21 0.4× 24 0.6× 13 0.4× 17 420
Alisa Tubsuwan Thailand 13 185 1.1× 59 0.5× 18 0.4× 16 0.4× 25 0.7× 34 288
María Luciana Negro‐Demontel Uruguay 6 110 0.7× 55 0.5× 19 0.4× 18 0.4× 23 0.7× 8 331
Irit Shoval Israel 9 291 1.7× 50 0.4× 49 1.0× 24 0.6× 6 0.2× 19 523

Countries citing papers authored by Salla M. Kangas

Since Specialization
Citations

This map shows the geographic impact of Salla M. Kangas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salla M. Kangas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salla M. Kangas more than expected).

Fields of papers citing papers by Salla M. Kangas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salla M. Kangas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salla M. Kangas. The network helps show where Salla M. Kangas may publish in the future.

Co-authorship network of co-authors of Salla M. Kangas

This figure shows the co-authorship network connecting the top 25 collaborators of Salla M. Kangas. A scholar is included among the top collaborators of Salla M. Kangas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salla M. Kangas. Salla M. Kangas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huhtaniska, Sanna, Tytti Pokka, Salla M. Kangas, et al.. (2025). Phenotypic Heterogeneity in Genetic and Acquired Pediatric Cerebellar Disorders. Movement Disorders. 40(9). 1851–1862.
3.
Kangas, Salla M., Estrella López‐Martín, Timothy Feyma, et al.. (2024). Hyperkinetic Movement Disorder Caused by the Recurrent c. 892C >T NACC1 Variant. Movement Disorders Clinical Practice. 11(6). 708–715. 1 indexed citations
4.
Kangas, Salla M., Elisa Rahikkala, Tytti Pokka, et al.. (2024). Brain MRI findings in paediatric genetic disorders associated with white matter abnormalities. Developmental Medicine & Child Neurology. 67(2). 186–194. 1 indexed citations
5.
Rahikkala, Elisa, Mika Kallio, Salla M. Kangas, et al.. (2024). A novel pathogenic SLC12A5 missense variant in epilepsy of infancy with migrating focal seizures causes impaired KCC2 chloride extrusion. Frontiers in Molecular Neuroscience. 17. 1372662–1372662. 4 indexed citations
6.
Kangas, Salla M., Päivi Vieira, Elisa Rahikkala, et al.. (2023). Infantile onset encephalomyopathy, retinopathy, optic atrophy, and mitochondrial DNA depletion associated with a novel pathogenic DHX16 variant. Clinical Genetics. 104(6). 686–693. 2 indexed citations
7.
Ohigashi, Takuji, Antti M. Salo, Reetta Vuolteenaho, et al.. (2023). Scanning transmission soft X-ray spectromicroscopy of mouse kidney and liver. Journal of Electron Spectroscopy and Related Phenomena. 266. 147368–147368.
8.
Kangas, Salla M., Bishwa Ghimire, Pirkko Mattila, et al.. (2022). Analysis of human brain tissue derived from DBS surgery. Translational Neurodegeneration. 11(1). 22–22. 7 indexed citations
9.
10.
Heikkinen, Anne, Salla M. Kangas, Marika Karikoski, et al.. (2021). Modeling Rare Human Disorders in Mice: The Finnish Disease Heritage. Cells. 10(11). 3158–3158. 4 indexed citations
11.
Suo‐Palosaari, Maria, Salla M. Kangas, Elisa Rahikkala, et al.. (2021). Epidemiological, clinical, and genetic characteristics of paediatric genetic white matter disorders in Northern Finland. Developmental Medicine & Child Neurology. 63(9). 1066–1074. 7 indexed citations
12.
Pyle, Angela, Maria Suo‐Palosaari, Jennifer Duff, et al.. (2020). Homozygous TAF1C variants are associated with a novel childhood‐onset neurological phenotype. Clinical Genetics. 98(5). 493–498. 3 indexed citations
13.
Kangas, Salla M., Steffen Ohlmeier, Ilkka Pietilä, et al.. (2020). Variant in NHLRC2 leads to increased hnRNP C2 in developing neurons and the hippocampus of a mouse model of FINCA disease. Molecular Medicine. 26(1). 123–123. 5 indexed citations
14.
Schreiber, John M., Salla M. Kangas, Katri Pylkäs, et al.. (2019). Novel variants and phenotypes widen the phenotypic spectrum of GABRG2-related disorders. Seizure. 69. 99–104. 20 indexed citations
15.
Kangas, Salla M., Steffen Ohlmeier, Raija Sormunen, et al.. (2016). An approach to comprehensive genome and proteome expression analyses in Schwann cells and neurons during peripheral nerve myelin formation. Journal of Neurochemistry. 138(6). 830–844. 9 indexed citations
16.
Tejesvi, Mysore V., Miika Arvonen, Salla M. Kangas, et al.. (2015). Faecal microbiome in new-onset juvenile idiopathic arthritis. European Journal of Clinical Microbiology & Infectious Diseases. 35(3). 363–370. 70 indexed citations
17.
Myllykoski, Matti, Kouichi Itoh, Salla M. Kangas, et al.. (2012). The N‐terminal domain of the myelin enzyme 2′,3′‐cyclic nucleotide 3′‐phosphodiesterase: direct molecular interaction with the calcium sensor calmodulin. Journal of Neurochemistry. 123(4). 515–524. 19 indexed citations
18.
Wang, Chaozhan, Matti Myllykoski, Salla M. Kangas, et al.. (2009). Structural analysis of the complex between calmodulin and full-length myelin basic protein, an intrinsically disordered molecule. Amino Acids. 39(1). 59–71. 41 indexed citations
19.
Nissinen, Marja, et al.. (2008). Myelination in mouse dorsal root ganglion/Schwann cell cocultures. Molecular and Cellular Neuroscience. 37(3). 568–578. 66 indexed citations
20.
Nissinen, Marja, Salla M. Kangas, Maria H. Alanne, et al.. (2007). Isolation, purification and expansion of myelination‐competent, neonatal mouse Schwann cells. European Journal of Neuroscience. 26(4). 953–964. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026